
Align Biopharma’s IT consortium is up to 23 members
Veeva-led group is developing nonproprietary identity- and consent-management standards for HCPs
Since its introduction
All this is being done, according to Align Biopharma president Henry Levy, to streamline HCP digital access and interaction with industry-sponsred websites and portals. “It’s clear there is a significant opportunity to improve the digital experience for healthcare professionals,” he said, in a statement. “We’re attracting the best experts that are shaping the standards to simplify how HCPs get the important treatment information they need.”
The effort began with Veeva’s sponsorship and support, but is meant to be independent and self-sustaining. Six pharma companies signed on originally; they have been joined by additional firms, as well as such technology and service providers as Adobe, Exostar, Accenture, Cognizant, Deloitte, and Mavens. (A complete list is on the Align
Identity management and features like single sign-on are active parts of today's digital work environment; Exostar (for one) has business with individual pharma companies who have set up such capabilities internally, and the
Newsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.